Direct Ethibloc injection in benign bone cysts: preliminary report on four patients.
Benign bone cysts often require treatment in order to prevent pathological fracture. We report preliminary experience with percutaneous injection of Ethibloc in four children (8-15 years old) presenting with benign bone cysts: two were aneurysmal bone cysts, two were unicameral bone cysts. All the patients were followed up for 12-18 months. Healing was satisfactory in all cases and no complications occurred.
Adamsbaum
C
C
Department of Radiology, Hôpital Saint Vincent de Paul, Paris, France.
Kalifa
G
G
Seringe
R
R
Dubousset
J
J
D000293:Adolescent; D001845:Bone Cysts / Q000000981:diagnostic imaging / Q000628:therapy*; D002648:Child; D003973:Diatrizoate; D004338:Drug Combinations; D005227:Fatty Acids; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D011409:Propylene Glycols; D011506:Proteins / Q000008:administration & dosage*; D015641:Radiography, Interventional; D015028:Zein
D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution